BioSpace News Archive

TherapeuticsMD, Inc. announced that the company will participate in the 2019 Cantor Global Healthcare Conference in New York City.

Nura announced that it will begin providing free Narcan® kits and training directly to select patients who take opiate analgesics.

Emmaus Life Sciences, Inc. announced it is approved to have its common stock trade on the OTCQB marketplace, effective September 26, 2019.

Executive team addition reinforces increased investment in AI, machine learning and analytics-enabled solutions to improve patient access and outcomes

Pyramid Systems, a women-owned small business providing technology solutions to the federal government, is excited to announce that Chris Bishop has joined the company as its Chief Growth Officer.

Analyst conference call with breast cancer specialist to be held at 2:30 p.m. Central European Summer Time (CEST)/8:30 a.m. Eastern Daylight Time (EDT)

ArQule, Inc. announced that Peter Lawrence, President and Chief Operating Officer, and Marc Schegerin, Chief Financial Officer and Head of Strategy, will present at the 2019 Cantor Global Healthcare Conference on Thursday, October 3, 2019 at 2:25 p.m. ET at the InterContinental New York Barclay in New York City.

Aimmune Therapeutics, Inc. announced that its President and Chief Executive Officer, Jayson Dallas, M.D., will present at the Cantor Global Healthcare Conference on Thursday, October 3, 2019 at 8:20 a.m. E.T. in New York City.

Former head of IHS Markit Energy, Chemicals and Agribusiness Division to lead company for Intrexon’s Methane Bioconversion Platform (MBP)

New integration allows Epic users to search 4.6 million Phynd provider profiles, and to quickly find and enroll high-quality provider profiles directly into Hyperspace